These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37663385)

  • 21. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Pourdowlat G; Mousavinasab SR; Farzanegan B; Kashefizadeh A; Meybodi ZA; Jafarzadeh M; Baniasadi S
    Trials; 2021 Jan; 22(1):60. PubMed ID: 33461602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a Persian herbal medicine compound on coronavirus disease 2019 (COVID-19): A randomized clinical trial.
    Setayesh M; Karimi M; Zargaran A; Abousaidi H; Shahesmaeili A; Amiri F; Hasheminasab FS
    Integr Med Res; 2022 Sep; 11(3):100869. PubMed ID: 35783542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial.
    Karimi M; Zarei A; Soleymani S; Jamalimoghadamsiahkali S; Asadi A; Shati M; Jafari M; Rezadoost H; Kordafshar G; Naghizadeh A; Mardi R; Namiranian P; Khamechi SP; Ansari N; Adel Mehraban MS; Aliakbarzadeh H; Khanavi M; Esmaealzadeh N; Moravveji A; Salahi M; Khoi M; Razzaghi R; Banafshe HR; Alizadeh M; Akhbari M; Atharizadeh M; Izadikhah A; Elsagh M; Hossein Zade Ghahnavieh M; Eghbalian F; Vanai A; Izadi H; Moravej SAA; Jazayeri SF; Bayat H; Emadi Koochak H; Zargaran A
    Phytother Res; 2021 Nov; 35(11):6295-6309. PubMed ID: 34606123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DRY CUPPING IN CHILDREN WITH FUNCTIONAL CONSTIPATION: A RANDOMIZED OPEN LABEL CLINICAL TRIAL.
    Shahamat M; Daneshfard B; Najib KS; Dehghani SM; Tafazoli V; Kasalaei A
    Afr J Tradit Complement Altern Med; 2016; 13(4):22-28. PubMed ID: 28852716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy trial of cupping and serkangabin versus conventional therapy of migraine headaches: A randomized, open-label, comparative efficacy trial.
    Firoozabadi MD; Navabzadeh M; Roudsari MK; Zahmatkash M
    J Res Med Sci; 2014 Dec; 19(12):1134-9. PubMed ID: 25709653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial Activity of the Essential Oil Obtained from the Seed and Oleo-Gum-Resin of
    Daneshkazemi A; Zandi H; Davari A; Vakili M; Emtiazi M; Lotfi R; Masoumi SMR
    Front Dent; 2019; 16(2):113-120. PubMed ID: 31777852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encapsulation of probiotic Lactobacillus acidophilus ATCC 4356 in alginate-galbanum (Ferula Gummosa Boiss) gum microspheres and evaluation of the survival in simulated gastrointestinal conditions in probiotic Tahini halva.
    Sekhavatizadeh SS; Afrasiabi F; Montaseri Z
    Braz J Microbiol; 2023 Sep; 54(3):1589-1601. PubMed ID: 37515666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cupping treatment combined with antibiotics for bacterial pneumonia in children: a randomized controlled trial].
    Xu Y; Cui ST; Bai LY; Yang JJ; Li J; Xie TL; Zhang YL; Wang D; Wu S; Wang ZT; Sun LP
    Zhongguo Zhen Jiu; 2021 Mar; 41(3):283-7. PubMed ID: 33798311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
    Li J; Zhang C; Wu Z; Wang G; Zhao H
    Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial.
    Shah MR; Fatima S; Khan SN; Ullah S; Himani G; Wan K; Lin T; Lau JYN; Liu Q; Lam DSC
    Front Med (Lausanne); 2022; 9():928468. PubMed ID: 35979216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.